The partnership between Aldevron (Fargo, N.D.) and Ginkgo Bioworks (Boston) has resulted in an improvement in the manufacturing yield of the vaccinia capping enzyme (VCE). VCEs are often used in the production of mRNA vaccines and therapeutics. The new production protocol is more than 10 times more efficient than the prior process, according to a…